Form 8-K - Current report:
SEC Accession No. 0001213900-25-032083
Filing Date
2025-04-15
Accepted
2025-04-15 16:10:37
Documents
14
Period of Report
2025-04-12
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0238185-8k_abpro.htm   iXBRL 8-K 32198
  Complete submission text file 0001213900-25-032083.txt   251579

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abp-20250412.xsd EX-101.SCH 3854
3 XBRL DEFINITION FILE abp-20250412_def.xml EX-101.DEF 26755
4 XBRL LABEL FILE abp-20250412_lab.xml EX-101.LAB 36995
5 XBRL PRESENTATION FILE abp-20250412_pre.xml EX-101.PRE 25379
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0238185-8k_abpro_htm.xml XML 5990
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 25839601
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)